Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Generated: May 29, 2017

DrugPatentWatch Database Preview

Rosuvastatin calcium - Generic Drug Details

« Back to Dashboard

What are the generic sources for rosuvastatin calcium and what is the scope of rosuvastatin calcium freedom to operate?

Rosuvastatin calcium
is the generic ingredient in two branded drugs marketed by Changzhou Pharm, Hetero Labs Ltd V, Torrent Pharms Ltd, Accord Hlthcare, Apotex Inc, Biocon Ltd, Cadila Pharms Ltd, Mylan Pharms Inc, Jubilant Generics, Alkem Labs Ltd, IPR, Teva Pharms Usa, Watson Labs Inc, Par Pharm Inc, Sun Pharma Global, Aurobindo Pharma Ltd, Sandoz Inc, and Glenmark Pharms, and is included in eighteen NDAs. There are six patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

Rosuvastatin calcium has two hundred and fifteen patent family members in fifty-two countries.

There are thirty-eight drug master file entries for rosuvastatin calcium. Forty-one suppliers are listed for this compound.

Summary for Generic Name: rosuvastatin calcium

Drug Master File Entries: see list38
Suppliers / Packagers: see list41
Bulk Api Vendors: see list67
Clinical Trials: see list904
Patent Applications: see list242
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:rosuvastatin calcium at DailyMed

Pharmacology for Ingredient: rosuvastatin calcium

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Accord Hlthcare
rosuvastatin calcium
TABLET;ORAL206434-004Oct 31, 2016ABRXNoNo► Subscribe► Subscribe
Glenmark Pharms
rosuvastatin calcium
TABLET;ORAL079172-003Jul 19, 2016ABRXNoNo► Subscribe► Subscribe
rosuvastatin calcium
TABLET;ORAL021366-002Aug 12, 2003ABRXYesNo7,030,152*PED► SubscribeY► Subscribe
Torrent Pharms Ltd
rosuvastatin calcium
TABLET;ORAL201619-002Oct 31, 2016ABRXNoNo► Subscribe► Subscribe
rosuvastatin calcium
TABLET;ORAL021366-005Aug 12, 2003ABRXYesYes► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Anticipate P&T budget requirements
  • Analyze global market entry opportunities
  • Predict branded drug patent expiration

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus